All the news Showing 10 of 42 articles from: International policyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection World Health Organization / 25 February 2016 Hepatitis C-free Europe is possible by 2030 Hepatitis B & C Public Policy Association / 17 February 2016 Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025 Keith Alcorn / 15 September 2015 Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global funding of $11 billion per year by 2025, Stefan Wiktor of the WHO Hepatitis Programme told ... World Health Organization calls for ambitious global targets for viral hepatitis control Keith Alcorn / 03 September 2015 The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of viral hepatitis, signalling a major increase in momentum towards elimination of viral hepatitis by 2030. Dr ... The case for keeping viral hepatitis in the Sustainable Development Goals Sci.dev.net / 15 April 2015 Tackle hepatitis C to save people living with HIV Citizen News Service (via Asia Tribune) / 26 June 2014 New hepatitis resolution is passed at world health assembly; challenges World Health Organization and member states to act Treatment Action Group / 23 May 2014 WHA Adopts Resolution On Hepatitis; Member States Concerned Over High Prices Intellectual Property Watch / 23 May 2014 Defuse Hepatitis C, the Viral Time Bomb: Test and Treat Hepatitis C Treatment Action Group / 21 May 2014 End this neglect of viral hepatitis The Guardian / 12 August 2013 ← Prev12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive